4NOVEMBER - 2021TECH OUTLOOKHow Allogeneic Stem Cell Therapies Can Transform Prospects in Inherited Retinal DiseasesIN MY OPINIONGil Carrasquinho, VP Head of Cell Therapy, Santen0812CIO INSIGHTSPhilippe Caby, CIO, Centrient PharmaceuticalsThree Steps to Succeed with Digital Transformation in Pharma?19COVER STORYGENSCRIPTPROBIOBIOLOGICS BACKED BY PHARMACEUTICAL PROFICIENCYDR. BRIAN MIN, CEO
< Page 3 | Page 5 >